This Article  • Full text  • PDF  • JAMA Report Video  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Pain  • Substance Abuse/ Alcoholism  • Drug Therapy  • Adverse Effects  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Aron J. Hall, DVM, MSPH; Joseph E. Logan, PhD; Robin L. Toblin, PhD, MPH; James A. Kaplan, MD; James C. Kraner, PhD; Danae Bixler, MD, MPH; Alex E. Crosby, MD, MPH; Leonard J. Paulozzi, MD, MPH

JAMA. 2008;300(22):2613-2620.

Context  Use and abuse of prescription narcotic analgesics have increased dramatically in the United States since 1990. The effect of this pharmacoepidemic has been most pronounced in rural states, including West Virginia, which experienced the nation's largest increase in drug overdose mortality rates during 1999-2004.

Objective  To evaluate the risk characteristics of persons dying of unintentional pharmaceutical overdose in West Virginia, the types of drugs involved, and the role of drug abuse in the deaths.

Design, Setting, and Participants  Population-based, observational study using data from medical examiner, prescription drug monitoring program, and opiate treatment program records. The study population was all state residents who died of unintentional pharmaceutical overdoses in West Virginia in 2006.

Main Outcome Measures  Rates and rate ratios for selected demographic variables. Prevalence of specific drugs among decedents and proportion that had been prescribed to decedents. Associations between demographics and substance abuse indicators and evidence of pharmaceutical diversion, defined as a death involving a prescription drug without a documented prescription and having received prescriptions for controlled substances from 5 or more clinicians during the year prior to death (ie, doctor shopping).

Results  Of 295 decedents, 198 (67.1%) were men and 271 (91.9%) were aged 18 through 54 years. Pharmaceutical diversion was associated with 186 (63.1%) deaths, while 63 (21.4%) were accompanied by evidence of doctor shopping. Prevalence of diversion was greatest among decedents aged 18 through 24 years and decreased across each successive age group. Having prescriptions for a controlled substance from 5 or more clinicians in the year prior to death was more common among women (30 [30.9%]) and decedents aged 35 through 44 years (23 [30.7%]) compared with men (33 [16.7%]) and other age groups (40 [18.2%]). Substance abuse indicators were identified in 279 decedents (94.6%), with nonmedical routes of exposure and illicit contributory drugs particularly prevalent among drug diverters. Multiple contributory substances were implicated in 234 deaths (79.3%). Opioid analgesics were taken by 275 decedents (93.2%), of whom only 122 (44.4%) had ever been prescribed these drugs.

Conclusion  The majority of overdose deaths in West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primarily opioid analgesics.

Author Affiliations: Epidemic Intelligence Service (Drs Hall, Logan, and Toblin) and National Center for Injury Prevention and Control (Drs Logan, Toblin, Crosby, and Paulozzi), Centers for Disease Control and Prevention, Atlanta, Georgia; Division of Surveillance and Disease Control (Drs Hall and Bixler) and Office of the Chief Medical Examiner (Drs Kaplan and Kraner), West Virginia Department of Health and Human Resources, Charleston.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Prescription Opioids and Overdose Deaths
Noni A. Graham, Mark S. Gold, and Bruce A. Goldberger
JAMA. 2009;301(17):1766.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Richard D. Layne, Ronald J. Pellegrino, and Nathan M. Lerfald
JAMA. 2009;301(17):1766-1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Robert Newman
JAMA. 2009;301(17):1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths
Michael Merrick
JAMA. 2009;301(17):1767.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths—Reply
Aron J. Hall and Leonard J. Paulozzi
JAMA. 2009;301(17):1767-1768.
EXTRACT | FULL TEXT  

Prescription Opioids and Overdose Deaths—Reply
A. Thomas McLellan and Barbara J. Turner
JAMA. 2009;301(17):1768-1769.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Prescription Opioids, Overdose Deaths, and Physician Responsibility
A. Thomas McLellan and Barbara Turner
JAMA. 2008;300(22):2672-2673.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Concerns About Consensus Guidelines for QTc Interval Screening in Methadone Treatment
Krantz et al.
ANN INTERN MED 2009;151:218-219.
FULL TEXT  

Prescription Opioids and Overdose Deaths
Graham et al.
JAMA 2009;301:1766-1766.
FULL TEXT  

Prescription Opioids and Overdose Deaths
Newman
JAMA 2009;301:1767-1767.
FULL TEXT  

Prescription Opioids and Overdose Deaths
Layne et al.
JAMA 2009;301:1766-1767.
FULL TEXT  

The prediction of outcome in somatised patients undergoing elective lumbar surgery
Okoro and Sell
J Bone Joint Surg Br 2009;91-B:517-521.
ABSTRACT | FULL TEXT  

Unintentional Fatal Opioid Overdoses
JWatch General 2008;2008:7-7.
FULL TEXT  

Prescription Opioids, Overdose Deaths, and Physician Responsibility
McLellan and Turner
JAMA 2008;300:2672-2673.
FULL TEXT